![Bing Wu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bing Wu
Direttore/Membro del Consiglio presso Beijing Shenogen Pharma Group Ltd.
Profilo
Bing Wu currently works at Beijing Shenogen Pharma Group Ltd., as Director from 2019.
Mr. Wu received his graduate degree in 1999 from Shanghai University of Finance & Economics.
Posizioni attive di Bing Wu
Società | Posizione | Inizio |
---|---|---|
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | 01/10/2019 |
Formazione di Bing Wu
Shanghai University of Finance & Economics | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Bing Wu